MTCO1P31

Across TCGA pan-cancer cohorts, MTCO1P31 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MTCO1P31 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MTCO1P31 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTCO1P31 expression acts as an unfavorable survival marker, although some lineages such as BRCA and READ show a favorable association.

BRCA, READ, and LIHC are the cancer types where MTCO1P31 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Quartile	II,III,IV	0.985	0.941	.003	47	view →
READ	DFS	Tertile	II,III,IV	0.826	0.434	.011	33	view →
LIHC	DFS	Tertile	II,III,IV	0.243	0.486	<.001	28	view →
DLBC	DFS	Tertile	All	0.502	1.000	.006	23	view →
KICH	DFS	Tertile	All	0.319	0.937	.002	22	view →
ESCA	OS	Quartile	III,IV	0.731	0.314	.002	22	view →
PAAD	OS	Median	II,III,IV	0.640	0.338	.020	16	view →
THCA	OS	Tertile	All	0.957	0.989	.009	16	view →
COAD	OS	Tertile	IV	1.000	0.482	.015	15	view →
SARC	OS	Quartile	All	0.317	0.694	<.001	13	view →
KIRP	OS	Quartile	All	0.533	0.715	.017	13	view →
STAD	DFS	Quartile	III,IV	0.335	0.627	.014	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MTCO1P31–BRCA (OS)

Open the BRCA breakdown →